To date, published case reports of DCTN1–ALK fusion solid tumors included non-small cell lung cancer (NSCLC) (9–11), inflammatory myofibroblastic tumors (IMTs) (12, 13), Spitz tumors (14), and some rare types of neoplasms. The gene discussed is ALK; the disease is non-small cell lung carcinoma.